Topics

Memo to the Novartis CEO: When in doubt, give the FDA a heads-up by @pharmalot https://www.statnews.com/2019/08/13/memo-to-the-novartis-ceo-when-in-doubt-give-the-fda-a-heads-up/ …

10:14 EDT 14 Aug 2019 | STAT

Memo to the Novartis CEO: When in doubt, give the FDA a heads-up by https://www.statnews.com/2019/08/13/memo-to-the-novartis-ceo-when-in-doubt-give-the-fda-a-heads-up/ …

Original Article: Memo to the Novartis CEO: When in doubt, give the FDA a heads-up by @pharmalot https://www.statnews.com/2019/08/13/memo-to-the-novartis-ceo-when-in-doubt-give-the-fda-a-heads-up/ …

NEXT ARTICLE

More From BioPortfolio on "Memo to the Novartis CEO: When in doubt, give the FDA a heads-up by @pharmalot https://www.statnews.com/2019/08/13/memo-to-the-novartis-ceo-when-in-doubt-give-the-fda-a-heads-up/ …"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...